(2S,3R,4S,5R)-2-((6-CHLORO-2-IODO-9H-PURIN-9-YL)OXY)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL
Modify Date: 2024-01-06 20:05:25
(2S,3R,4S,5R)-2-((6-CHLORO-2-IODO-9H-PURIN-9-YL)OXY)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL structure
|
Common Name | (2S,3R,4S,5R)-2-((6-CHLORO-2-IODO-9H-PURIN-9-YL)OXY)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL | ||
|---|---|---|---|---|
| CAS Number | 313477-85-9 | Molecular Weight | 412.57 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H10ClIN4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (2S,3R,4S,5R)-2-((6-CHLORO-2-IODO-9H-PURIN-9-YL)OXY)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL9H-Purine, 6-chloro-2-iodo-9-β-D-ribofuranosyl- (6-CHLORO-2-IODOPURINE-9-RIBOSIDE) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | (2S,3R,4S,5R)-2-((6-Chloro-2-iodo-9H-purin-9-yl)-oxy)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
|---|---|
| Synonym | More Synonyms |
| Description | 9H-Purine, 6-chloro-2-iodo-9-β-D-ribofuranosyl- (6-CHLORO-2-IODOPURINE-9-RIBOSIDE) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C10H10ClIN4O4 |
|---|---|
| Molecular Weight | 412.57 |
| Exact Mass | 427.93800 |
| PSA | 122.75000 |
|
~54%
(2S,3R,4S,5R)-2... CAS#:313477-85-9 |
| Literature: Bressi; Choe; HoughHough; Buckner; Van Voorhis; Verlinde; Hol; Gelb Journal of Medicinal Chemistry, 2000 , vol. 43, # 22 p. 4135 - 4150 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
CAS#:35109-88-7| 6-Chloro-2-iodopurine riboside |
| 6-CHLORO-2-IODOPURINE-9-RIBOSIDE |